Ikena Oncology Announces 1-for-12 Reverse Stock Split Ahead of Merger with Inmagene

Reuters
16 Jul
<a href="https://laohu8.com/S/IKNA">Ikena Oncology</a> Announces 1-for-12 Reverse Stock Split Ahead of Merger with Inmagene

Ikena Oncology Inc. has announced a 1-for-12 reverse stock split of its common stock, effective around the end of July 2025. This move will reduce the number of issued and outstanding shares from approximately 48.2 million to approximately 4 million. The company's common stock will begin trading on Nasdaq on a split-adjusted basis at that time, coinciding with the anticipated closing of its merger with Inmagene Biopharmaceuticals. Following the merger, the combined company will be renamed ImageneBio, Inc. and trade under the ticker symbol "IMA."

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ikena Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9495023-en) on July 15, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10